In vitro removal of anti-infective agents by a novel cytokine adsorbent system.


Journal

The International journal of artificial organs
ISSN: 1724-6040
Titre abrégé: Int J Artif Organs
Pays: United States
ID NLM: 7802649

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 14 12 2018
medline: 16 4 2019
entrez: 15 12 2018
Statut: ppublish

Résumé

The aim of this study is to describe the in vitro adsorption of anti-infective drugs onto an extracorporeal cytokine adsorber. Various anti-infective drugs (β-lactams, quinolones, aminoglycosides, glycopeptides, azole antimycotics) were prepared in normal saline 0.9% and human albumin 5%, and pumped through a cytokine cartridge (CytoSorb Observed mean clearance of the drugs in normal saline was 1.22 ± 0.07 L/h. In human albumin, clearance was 1.29 ± 0.08 L/h. In reconstituted blood, clearance of meropenem decreased from 5.4 to 1.4 L/h and for ciprofloxacin from 6.3 to 4.3 L/h within the first 1.5 h because of early drug adsorption. Continuous renal replacement therapy clearance measured without CytoSorb was stable at 2 and 1.7 L/h, respectively. Approximately 400 mg of meropenem and 300 mg of ciprofloxacin had been adsorbed by CytoSorb, suggesting that these amounts are the maximum adsorptive capacity for these drugs. In these settings, all tested drugs were adsorbed by the cartridge in relevant amounts. The identified maximum adsorptive capacity and the rapid decline in concentration during the first 1.5 h of CytoSorb use suggest that the administration of an additional dose within the first hours of CytoSorb treatment may be reasonable. In addition, early therapeutic drug monitoring should be considered.

Identifiants

pubmed: 30545255
doi: 10.1177/0391398818812601
doi:

Substances chimiques

Albumins 0
Anti-Infective Agents 0
Cytokines 0
Polymers 0
Saline Solution 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-64

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

Christina König (C)

1 Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
2 Hospital Pharmacy, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Anka C Röhr (AC)

3 Hospital Pharmacy, Heidenheim General Hospital, Heidenheim, Germany.

Otto R Frey (OR)

3 Hospital Pharmacy, Heidenheim General Hospital, Heidenheim, Germany.

Alexander Brinkmann (A)

4 Department of Anaesthesia and Critical Care Medicine, Heidenheim General Hospital, Heidenheim, Germany.

Jason A Roberts (JA)

5 Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia.
6 Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
7 Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

Dominic Wichmann (D)

1 Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Stephan Braune (S)

1 Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Stefan Kluge (S)

1 Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Axel Nierhaus (A)

1 Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH